1. Home
  2. CNDT vs PRQR Comparison

CNDT vs PRQR Comparison

Compare CNDT & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Conduent Incorporated

CNDT

Conduent Incorporated

HOLD

Current Price

$1.61

Market Cap

234.2M

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.99

Market Cap

262.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNDT
PRQR
Founded
2016
2012
Country
United States
Netherlands
Employees
51000
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.2M
262.5M
IPO Year
2016
2014

Fundamental Metrics

Financial Performance
Metric
CNDT
PRQR
Price
$1.61
$1.99
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$7.25
AVG Volume (30 Days)
935.5K
847.8K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,042,000,000.00
N/A
Revenue This Year
$2.01
N/A
Revenue Next Year
$4.06
$13.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.15
$1.33
52 Week High
$2.98
$3.10

Technical Indicators

Market Signals
Indicator
CNDT
PRQR
Relative Strength Index (RSI) 46.11 45.80
Support Level $1.35 $1.91
Resistance Level $1.62 $2.25
Average True Range (ATR) 0.11 0.13
MACD 0.00 -0.04
Stochastic Oscillator 28.57 3.19

Price Performance

Historical Comparison
CNDT
PRQR

About CNDT Conduent Incorporated

Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation, as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments, namely Commercial Industries, which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas, of which the majority of revenue is generated in the United States.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: